Effect of insulin-like growth factor-I treatment on serum androgens and testicular and penile size in males with Laron syndrome (primary growth hormone resistance)

European Journal of Endocrinology

Volumn 138, Issue 2, 1998, Pages 176-180

  Laron, Z ^a,b   Klinger, B ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; SOMATOMEDIN C;

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG EFFECT; GROWTH HORMONE DEFICIENCY; HORMONAL REGULATION; HORMONE RESISTANCE; HUMAN; LARON SYNDROME; MALE; PENIS ERECTION; PRIORITY JOURNAL; RECOMBINANT DNA TECHNOLOGY; SEXUAL DEVELOPMENT; TESTIS FUNCTION;

ADOLESCENT; ADULT; ANDROGENS; ANDROSTENEDIONE; CHILD; CHILD, PRESCHOOL; FOLLICLE STIMULATING HORMONE; GROWTH DISORDERS; HUMANS; INFANT; INSULIN-LIKE GROWTH FACTOR I; LUTEINIZING HORMONE; MALE; PENIS; RECOMBINANT PROTEINS; TESTIS; TESTOSTERONE;

EID: 0031936362     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1380176     Document Type: Article

References (22)

1. Laron Z, Pertzelan A & Mannheimer S. Genetic pituitary dwarfism with high serum concentration of growth hormone. A new inborn error of metabolism? Israel Journal of Medical Sciences 1966 2 152-155.
2. Laron Z. Prismatic cases: Laron syndrome (primary growth hormone resistance). From patient to laboratory to patient. Journal of Clinical Endocrinology and Metabolism 1995 80 1526-1531.
3. Laron Z & Sarel R. Penis and testicular size in patients with growth hormone insufficiency. Acta Endocrinologica 1970 63 625-633.
4. Laron Z, Pertzelan A, Karp M, Keret R, Eshet R & Silbergeid A. Laron syndrome: a unique model of IGF-I deficiency. Pediatric and Adolescent Endocrinology 1993 24 3-23.
5. Goodman HG, Grumbach MM & Kaplan SL. Growth and growth hormone. II. A comparison of isolated growth hormone deficiency and multiple pituitary hormone deficiencies in 35 patients with idiopathic hypopituitary dwarfism. New England Journal of Medicine 1968 278 57-68.
6. Niwa M, Sato Y, Saito Y, Uchiyama F, Ono H, Yamashita M et al. Chemical synthesis, cloning and expression of genes for human somatomedin C (insulin like growth factor I) and 59Val somatomedin C. Annals of the New York Academy of Sciences 1986 469 31-52.
7. Silbergeld A, Litwin A, Bruchis S, Varsano I & Laron Z. Insulin-like growth factor (IGF-I) in healthy children, adolescents and adults as determined by a radioimmunoassay specific for the synthetic 53-70 peptide region. Clinical Endocrinology 1986 25 67-74.
8. Laron Z & Klinger B. IGF-I treatment of adult patients with Laron syndrome: preliminary results. Clinical Endocrinology 1994 41 631-638.
9. Klinger B, Anin S, Silbergeld A, Eshet R & Laron Z. Development of hyperandrogenism during treatment with insulin-like growth factor-I (IGF-I) of female patients with Laron syndrome. Clinical Endocrinology 1998 48 (In Press).
10. Martin LG, Clark JW & Connor TB. Growth hormone secretion enhanced by androgens. Journal of Clinical Endocrinology and Metabolism 1968 28 425-428.
11. Illig R & Prader A. Effect of testosterone on growth hormone secretion in patients with anorchia and delayed puberty. Journal of Clinical Endocrinology and Metabolism 1970 30 615-618.
12. Lippe B, Wong SLR & Kaplan SA. Simultaneous assessment of growth hormone and ACTH reserve in children pretreated with diethylstilbestrol. Journal of Clinical Endocrinology and Metabolism 1971 33 949-956.
13. Mauras N, Blizzard RM, Link K, Johnson ML, Rogol AD & Veldhuis JD. Augmentation of growth hormone secretion during puberty: evidence for a pulse amplitude modulated phenomenon. Journal of Clinical Endocrinology and Metabolism 1987 64 596-601.
14. Silbergeld A, Lazar L, Erster B, Keret R, Tepper R & Laron Z. Serum growth hormone binding protein activity in healthy neonates, children and young adults: correlation with age, height and weight. Clinical Endocrinology 1989 31 295-303.
15. Kamp GA, Reckers-Mombarg LTM & Wit JM. Does GH treatment affect pubertal timing in children with idiopathic short stature? Highlights 1997 5 12-15.
16. Laron Z, Sarel R & Pertzelan A. Puberty in Laron-type dwarfism. European Journal of Pediatrics 1980 134 79-83.
17. Pertzelan A, Lazar L, Linger B & Laron Z. Puberty in fifteen patients with Laron syndrome: a longitudinal study. Pediatric and Adolescent Endocrinology 1993 24 27-33.
18. Barbieri RL, Smith S & Ryan K. The role of hyperinsulinemia in the pathogenesis of ovarian hyperandrogenism. Fertility and Sterility 1988 50 197-212.
19. Willis D & Franks S. Insulin action in human granulosa cells from normal and polycystic ovaries is mediated by the insulin receptor and not the type-I insulin-like growth factor receptor. Journal of Clinical Endocrinology and Metabolism 1985 80 3788-3790.
20. Bergh C, Olsson JH & Hillensjo T. Effect of insulin-like growth factor-I on steroidogenesis in cultured human granulosa cells. Acta Endocrinologica 1991 125 177-185.
21. Shoham Z, Conway GS, Ostergaard H, Lahlon N, Bouchard P & Jacobs HS. Cotreatment with growth hormone for induction of spermatogenesis in patients with hypogonadotropic hypogonadism. Fertility and Sterility 1992 57 1044-1055.
22. Breier BH, Vickers MH, Gravance CG & Casey PJ. Growth hormone (GH) therapy markedly increases the motility of spermatozoa and the concentration of insulin-like growth factor I in seminal vesicle fluid in the male GH-deficient dwarf rat. Endocrinology 1996 137 4061-4064.